Impact Biomedical Inc. (IBO) vs IGC Pharma, Inc. (IGC)
- Impact Biomedical Inc. IBO 2.68 −15.19%
- IGC Pharma, Inc. IGC 0.25 0.00%
Impact Biomedical Inc. and IGC Pharma, Inc. are both Biotechnology companies. Impact Biomedical Inc. and IGC Pharma, Inc. are of similar size ($27.0M and $26.3M). IGC Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 0.2×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs −795.5%) and the higher return on invested capital (−22.8% vs −91.5%). Across the 16 metrics below, Impact Biomedical Inc. leads on 10 and IGC Pharma, Inc. on 6.
Valuation
Profitability
| Metric | IBO | IGC | Biotechnology median |
|---|---|---|---|
| Gross margin | (1,111.43%) | 32.33% | 65.16% |
| Operating margin | (14,600.00%) | (912.44%) | 0.00% |
| Net margin | 2,254.29% | (795.46%) | 0.00% |
| Free cash flow margin | (1,451.43%) | (516.53%) | 0.00% |
| Return on equity | 24.01% | (143.46%) | (56.36%) |
| Return on assets | 4.41% | (100.44%) | (48.04%) |
| Return on invested capital | (22.81%) | (91.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack